Adults 18 to 60, male only, with Male Infertility or Obesity. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Sperm ConcentrationPrimary· 16 weeks
The number of sperm per millimeter of semen. Sperm concentration is an important factor affecting male fertility. It is calculated on a standard semen analysis
Study A (men with normal sperm concentration)
Group
Value
95% CI
Low Energy Diet
53.6
± 36.4
NHS Advice on Healthy Eating
58.5
± 32.8
Study B (men with low sperm concentration)
Group
Value
95% CI
Low Energy Diet
20.1
± 59.16
NHS Advice on Healthy Eating
15
± 16.8
Total MotilitySecondary· 16 weeks
Total motility refers to the percentage of sperm making any sort of movement.
men with a normal sperm concentration
Group
Value
95% CI
Low Energy Diet
59.5
± 9.6
NHS Advice on Healthy Eating
60.8
± 6.3
men with a low sperm concentration
Group
Value
95% CI
Low Energy Diet
48.9
± 12
NHS Advice on Healthy Eating
45.4
± 16.1
Progressive MotilitySecondary· 16 weeks
This type of motility refers to sperm that swim progressively, mostly in a straight line or large circles.
Study A (men with a normal sperm concentration)
Group
Value
95% CI
Low Energy Diet
53.3
± 10.4
NHS Advice on Healthy Eating
53.9
± 6.1
study B (men with a low sperm concentration)
Group
Value
95% CI
Low Energy Diet
42.8
± 14.1
NHS Advice on Healthy Eating
39.6
± 17
DNA Fragmentation Index (DFI)Secondary· 16 weeks
Percentage of sperm with fragmented DNA
Study A (men with a normal sperm concentration)
Group
Value
95% CI
Low Energy Diet
7.7
± 8.7
NHS Advice on Healthy Eating
19.8
± 9.6
study B (men with a low sperm concentration)
Group
Value
95% CI
Low Energy Diet
18.4
± 11.7
NHS Advice on Healthy Eating
11.2
± 11
TestosteroneSecondary· 16 weeks
Testosterone is the primary androgen in men and is synthesized in the testes. It can be measured in the serum.
Study A (men with a normal sperm concentration)
Group
Value
95% CI
Low Energy Diet, Men With Normal Sperm Concentration
13.6
± 5
NHS Advice on Healthy Eating, Men With Normal Sperm Concentration
12.4
± 2.8
study B (men with a low sperm concentration)
Group
Value
95% CI
Low Energy Diet, Men With Normal Sperm Concentration
15.6
± 6.2
NHS Advice on Healthy Eating, Men With Normal Sperm Concentration
13.7
± 4.1
Sex Hormone-Binding Globulin (SHBG)Secondary· 16 weeks
SHBG is a protein that is produced by the liver and binds tightly to the hormones testosterone, dihydrotestosterone (DHT) and oestradiol, and transports them in the blood in an inactive form.
(men with a normal sperm concentration)
Group
Value
95% CI
Low Energy Diet
30.2
± 12.6
NHS Advice on Healthy Eating
26.4
± 7
study B (men with a low sperm concentration)
Group
Value
95% CI
Low Energy Diet
24.2
± 12.4
NHS Advice on Healthy Eating
22.6
± 8.1
Reactive Oxygen Species (ROS)Secondary· 16 weeks
ROS is measured by oxidative colour change of luminol per second per million sperm.
Group
Value
95% CI
Low Energy Diet
13
3 – 39.1
NHS Advice on Healthy Eating
5
0.9 – 37.4
MorphologySecondary· 16 weeks
the percentage of sperm that appear normal when semen is viewed under a microscope
Study A (men with a normal sperm concentration)
Group
Value
95% CI
Low Energy Diet
1.2
± 1.1
NHS Advice on Healthy Eating
1.9
± 1.7
Study B (men with a low sperm concentration)
Group
Value
95% CI
Low Energy Diet
0.6
± 0.6
NHS Advice on Healthy Eating
1.3
± 1.7
Luteinizing Hormone (LH)Secondary· 16 weeks
LH produced in the pituitary gland, stimulates the leydig cells in the testes to produce testosterone.
FSH produced in the pituitary gland, stimulates the testes to produce mature sperm.
Study A (men with a normal sperm concentration)
Group
Value
95% CI
Low Energy Diet
3.8
± 2.1
NHS Advice on Healthy Eating
4.5
± 2.2
Study B (men with a low sperm concentration)
Group
Value
95% CI
Low Energy Diet
5.4
± 2.6
NHS Advice on Healthy Eating
5
± 2.4
Sponsor's own description
The purpose of this study is to determine the physiological effects of weight loss on seminal parameters in male participants with reduced reproductive capacity. Learning more about the physiological role of weight loss on reproductive function and metabolic profile of overweight and obese men may give us a better understanding of male fertility and improve the management of patients with reduced fertility. The effects of weight loss on seminal quality are not well understood.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07184086 — A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compare
· Phase 1
· recruiting
NCT03225339 — Diabetes Intervention Accentuating Diet and Enhancing Metabolism
· NA
· completed
Other recruiting trials for Male Infertility
Currently open trials in the same condition.
NCT07375238 — Effect of Daily Intake of Gazpacho on Semen Quality and Oxidative Stress
· NA
· recruiting
NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That
· NA
· active not recruiting
NCT06956287 — The Efficiency of a New Sperm-Wash Device for Intrauterine Insemination in Couples With Infertility
· NA
· recruiting
NCT06561451 — Live Birth Rate Between ICSI and AOA and ICSI Alone in Patients With Severe Teratospermia
· NA
· recruiting
NCT07056400 — Trial to Improve Fertilization Rate and Embryo Development in Intracytoplasmic Sperm Injection (ICSI) Cycles
· NA
· active not recruiting
Other Imperial College London trials
Trials by the same sponsor.
NCT06035861 — Endothelial Cell Activation and Total Pulmonary Resistance in PAH
· NA
· not yet recruiting
NCT07397455 — Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron Subvariants
· Phase 1
· not yet recruiting
NCT07422532 — A Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing
· NA
· not yet recruiting
NCT07389031 — Maralixibat for Intrahepatic Cholestasis of Pregnancy
· Phase 2
· not yet recruiting
NCT07358897 — Gender Affirming Hormone Therapy and Immune Function in Trans Individuals - The GIFT Study
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Imperial College London
Last refreshed: 7 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03553927.